-
Dr. Yuan Yu’s Insights: Advances in Esophageal Cancer Nursing and Future Directions for Enhanced Recovery | CACA Integrated Esophageal Cancer Academic
Oncology Frontier: During the conference’s esophageal cancer integrated nursing session, you gave a talk on recent research advancements in the field of esophageal cancer nursing. Could you share some of…
-
Minimally Invasive Surgery and Immunotherapy Dr. Yongde Liao Discusses New Pathways in Esophageal Cancer Treatment | CACA Integrated Esophageal Cancer
Oncology Frontier: You have extensive experience in minimally invasive surgery for esophageal cancer. How do you evaluate the effectiveness and safety of minimally invasive surgery? What clinical factors do you…
-
CSCO 2024: Dr. Zhiming Li Champions New Frontiers in Lymphoma Management
From September 25 to September 29, the 27th National Clinical Oncology Conference and CSCO Annual Meeting, organized by the Chinese Society of Clinical Oncology (CSCO) and the Beijing Xisike Clinical Oncology Research Foundation, was successfully held in Xiamen. During the conference, Hematology Frontier invited Dr. Zhiming Li from Sun Yat-sen University Cancer Center to share…
-
CAR-T vs. Bispecific Antibodies: Dr. Junmin Song’s Groundbreaking Myeloma Study at ESMO 2024
The 2024 Annual Meeting of the European Society for Medical Oncology (ESMO) was recently held in Barcelona, Spain. As one of the premier global oncology conferences, it brought together experts and scholars from around the world to share cutting-edge research and chart future directions. During the conference, Dr. Junmin Song from the Jacobi Medical Center,…
-
Dr. Conconi at ESMO 2024: Charting the Course for Hematologic Malignancies Treatment
The 2024 Annual Meeting of the European Society for Medical Oncology (ESMO) was recently held in Barcelona, Spain. As one of the top international conferences in the field of oncology, it gathered experts and scholars from around the world to share the latest research findings and explore future development directions. During this conference, several landmark…
-
ILCA 2024 Reveals: Sorafenib-Toripalimab and Anlotinib-Sintilimab Combos Yield Unprecedented Results in Liver Cancer
1. Two Studies Presented at ILCA Oncology Frontier: Professor Yang, you presented two studies at this year’s ILCA conference. Could you briefly introduce the key findings of each study? Professor…
-
CSCO 2024丨Dr. Hui Zhou: Challenges and Advances in Lymphoma Diagnosis and Treatment, from Standardization to Innovation
From September 25 to 29, 2024, the 27th Annual National Clinical Oncology Conference and 2024 CSCO Annual Meeting, hosted by the Chinese Society of Clinical Oncology (CSCO) and Beijing HopeRun…
-
Groundbreaking Honors at ILCA 2024: Celebrating Liver Cancer Research Milestones
The 2024 International Liver Cancer Association (ILCA) Conference recently held its highly anticipated awards ceremony in Rio de Janeiro, Brazil. This event attracted attention from liver cancer researchers worldwide, recognizing those who made significant contributions to the field over the past year. The ceremony aimed to further promote global collaboration and innovation in liver cancer…
Connecting Medical Expertise through Media